Called LlamaCon after Meta’s Llama family of generative AI models, the conference is scheduled to take place on April 29.

Meghan Markle's new brand logo is loaded with symbolism. Inside the deeper meaning of what the Duchess of Sussex chose for the As Ever crest.

The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has ...

The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development ...

DelveInsight's Biologics Drug Substance Manufacturing Market Insights report provides the current and forecast market ...

The company plans to launch five new biosimilars in the U.S. in the new fiscal year, starting in April, and is aspiring for double-digit market share for them, Biocon Biologics CEO Shreehas Tambe ...

Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a top executive told ...

Biocon plans IPO for biosimilars business by March 2026 Biosimilars are similar and relatively affordable versions of high-priced and complex biologics drugs used to treat illnesses such as cancer ...

Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core US market for its new launches, a top executive told ...

Kiran shares her visionary journey, insights, and innovations in advancing biotechnology through the development of Biocon.

Biocon Biologics has also gained market share, with oncology remaining a key focus area. The company recently received USFDA and European validation for its biosimilar denosumab, used in bone health ...